[HTML][HTML] Three times weekly dosing of daprodustat versus conventional epoetin for treatment of anemia in hemodialysis patients: ASCEND-TD: a phase 3 randomized …
Results Daprodustat three times weekly was noninferior to epoetin for mean change in
hemoglobin (model-adjusted mean treatment difference [daprodustat-epoetin],− 0.05; 95 …
hemoglobin (model-adjusted mean treatment difference [daprodustat-epoetin],− 0.05; 95 …
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients ASCEND-TD: A Phase 3 Randomized …
DW Coyne, AK Singh, RD Lopes… - Clinical Journal of the …, 2022 - profiles.wustl.edu
Background and objectives Daprodustat is a hypoxia-inducible factor prolyl hydroxylase
inhibitor (HIF-PHI) being investigated for the treatment of anemia of CKD. In this …
inhibitor (HIF-PHI) being investigated for the treatment of anemia of CKD. In this …
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized …
DW Coyne, AK Singh, RD Lopes… - Clinical journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background and objectives Daprodustat is a hypoxia-inducible factor prolyl hydroxylase
inhibitor (HIF-PHI) being investigated for the treatment of anemia of CKD. In this …
inhibitor (HIF-PHI) being investigated for the treatment of anemia of CKD. In this …
[HTML][HTML] Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 …
DW Coyne, AK Singh, RD Lopes… - Clinical Journal of the …, 2022 - ncbi.nlm.nih.gov
Results Daprodustat three times weekly was noninferior to epoetin for mean change in
hemoglobin (model-adjusted mean treatment difference [daprodustat-epoetin],− 0.05; 95 …
hemoglobin (model-adjusted mean treatment difference [daprodustat-epoetin],− 0.05; 95 …
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized …
DW Coyne, AK Singh, RD Lopes, CK Bailey… - Clinical Journal of the …, 2022 - europepmc.org
Results Daprodustat three times weekly was noninferior to epoetin for mean change in
hemoglobin (model-adjusted mean treatment difference [daprodustat-epoetin],-0.05; 95 …
hemoglobin (model-adjusted mean treatment difference [daprodustat-epoetin],-0.05; 95 …
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized …
DW Coyne, AK Singh, RD Lopes, CK Bailey… - Clinical Journal of the …, 2022 - europepmc.org
Results Daprodustat three times weekly was noninferior to epoetin for mean change in
hemoglobin (model-adjusted mean treatment difference [daprodustat-epoetin],-0.05; 95 …
hemoglobin (model-adjusted mean treatment difference [daprodustat-epoetin],-0.05; 95 …